Related Experiment Video
Updated: Aug 6, 2025

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
Kimyrsa and Orbactiv - A Tale of Two Formulations
Brittany T Jackson1, David B Cluck2, Andrés F Henao-Martínez3
1Department of Pharmacy, Mount Sinai Morningside, New York, NY, 10025, USA.
Kimyrsa, a new oritavancin formulation, offers shorter infusion times and better solution compatibility. Its pharmacokinetic and microbiologic profiles are similar to the original formulation, with limited real-world data currently available.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Oritavancin is a lipoglycopeptide antibiotic used for Gram-positive bacterial infections.
- A new formulation (NF) of oritavancin has been developed, distinct from the original formulation (OF).
Purpose of the Study:
- To compare the new formulation (NF) of oritavancin with its original formulation (OF).
- To evaluate the potential benefits and clinical utility of the new oritavancin formulation.
Main Methods:
- Comparative analysis of formulation characteristics.
- Review of pharmacokinetic and microbiologic profiles.
- Assessment of clinical data and real-world experience.
Main Results:
- The new formulation (NF) offers a shortened infusion time and enhanced solution compatibility compared to the original formulation (OF).
- Pharmacokinetic and microbiologic profiles remain largely similar between the NF and OF.
- Limited real-world experience currently exists for the NF.
Conclusions:
- The new oritavancin formulation provides practical advantages in administration.
- Its therapeutic role is anticipated to be comparable to the original formulation, pending further real-world data.
- Further clinical experience is needed to fully establish the NF's place in therapy among lipoglycopeptides.
Related Concept Videos
Bioequivalence: Overview
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...

